Clinical trial
Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use…
NCT00029614 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00029614 |
|---|---|
| Title | Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD |
| Official title | Psychopharmacology of Adolescents With AUD and ADHD |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Substance Use Disorders, Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine |
| Enrollment | 24 |
| Start date | May 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Jan 17, 2002 |
| Last update posted | Apr 28, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: